Effects Of Phase Feeding Different Levels Of Fungus Myceliated Grain On Broiler   Performance And Health by Jackson, Joi N.
North Carolina Agricultural and Technical State University 
Aggie Digital Collections and Scholarship 
Theses Electronic Theses and Dissertations 
2013 
Effects Of Phase Feeding Different Levels Of Fungus Myceliated 
Grain On Broiler Performance And Health 
Joi N. Jackson 
North Carolina Agricultural and Technical State University 
Follow this and additional works at: https://digital.library.ncat.edu/theses 
Recommended Citation 
Jackson, Joi N., "Effects Of Phase Feeding Different Levels Of Fungus Myceliated Grain On Broiler 
Performance And Health" (2013). Theses. 299. 
https://digital.library.ncat.edu/theses/299 
This Thesis is brought to you for free and open access by the Electronic Theses and Dissertations at Aggie Digital 
Collections and Scholarship. It has been accepted for inclusion in Theses by an authorized administrator of Aggie 
Digital Collections and Scholarship. For more information, please contact iyanna@ncat.edu. 
Effects of Phase Feeding Different Levels of Fungus Myceliated Grain on Broiler  
Performance and Health 
 Joi N. Jackson 
North Carolina A&T State University 
 
 
 
A thesis submitted to the graduate faculty 
in partial fulfillment of the requirements for the degree of 
MASTER OF SCIENCE  
Department: Animal Sciences 
Major: Animal Health Sciences 
Major Professor: Dr. Willie Willis 
Greensboro, North Carolina  
2013
i 
 
School of Graduate Studies 
North Carolina Agricultural and Technical State University 
This is to certify that the Master’s Thesis of 
 
 
Joi N. Jackson 
 
 
 
has met the thesis requirements of  
North Carolina Agricultural and Technical State University 
 
 
Greensboro, North Carolina 
2013 
 
 
Approved by: 
 
 
_____________________________    _____________________________  
Dr. Willie Willis                 Dr. Mulumebet Worku 
Major Professor Committee Member 
       
 
 
_____________________________    _____________________________  
Dr. Radiah Minor      Dr. Sang Oh 
Committee Member  Committee Member  
 
 
 
______________________________   _____________________________ 
Dr. Omoanghe Isikhuemhen     Dr. Ralph Noble 
Committee Member                 Department Chairperson 
 
 
 
______________________________ 
                                                Dr. Sanjiv Sarin 
                                                Dean, The Graduate School 
ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© Copyright by 
Joi N. Jackson 
2013 
iii 
 
Biographical Sketch 
 Joi N. Jackson was born in Orange, New Jersey on January 4, 1984. She was in the first 
graduating class of the Appomattox Regional Governors School in Petersburg, Virginia where 
she graduated with honors. After graduating from high school, she went on to attend Virginia 
State University to study Animal Science where she graduated cum laude. She then went on to 
attend North Carolina Agricultural and Technical State University to work on her master’s 
degree. She was accepted on the Graduate Merit Assistantship Scholarship and remained in 
excellent academic standing throughout the course of her graduate studies. She has participated 
in scientific conferences and farm related educational demonstrations. She has assisted 
undergraduates with laboratory procedures, participated in multiple research projects, conducted 
class lectures and has co-authored three publications. Her project was supported by the Evans-
Allen USDA grant funding. She is a candidate for the Master of Science degree in Animal 
Health Science. 
 
iv 
 
Dedication 
This thesis is dedicated to my mother, grandmother, brother and loving family. I could 
not love you more. I give a special recognition to my father who through sickness has shown me 
exceptional strength. Their love, support, patience and encouragement have helped me through 
many obstacles. Your dedication to my success has been an inspiration in which I am truly 
thankful. 
I shall be telling this with a sigh 
Somewhere ages and ages hence: 
Two roads diverged in the woods, and I - - 
I took the one less traveled by, 
                                   And that has made all the difference. 
- Robert Frost  
 
v 
 
Acknowledgements 
 Any serious writing project requires a great deal of concentration, focus, energy and time. 
I would like to thank God primarily for acknowledging my potential and giving me the insight 
and strength to follow my dreams. I thank him for guiding my steps meticulously throughout this 
entire journey. Without him I would not be where I am today.  
In loving memory of Mr. David Gantt Jr., a truly beautiful person and a beloved family 
friend. I will never forget your kindness. Thank you a million times over, for your friendship and 
generosity, it will never be forgotten.  
I wish to express my gratitude for my mentor, Dr. Willie Willis, for his motivation, 
supervision and guidance throughout the course of my studies. His enthusiasm in my work, 
belief in my abilities and assistance during research projects, paper writing and the preparation of 
my thesis were vital. Without him this would not have been possible. I would also like to extend 
my appreciation to my committee members, Dr. Worku, Dr. Minor, Dr. Oh and Dr. Omoanghe 
Isikhuemhen, for their guidance and support in my education and research. Your advice and 
support was truly appreciated.  
I give a deep heartfelt thanks to Ms. Murray, Mr. Bullock and Mr. Hooks for their 
continuous encouragement and support. Thank you for inspiring me. Your generosity in aiding 
me both in the laboratory and at the farm was appreciated more than you know.  
Last but never least; I would like to give a special thanks to my friends who have stuck 
by me through it all. I couldn’t ask for anything more. For through life’s journey you must often 
walk alone to uncover your undiscovered paths, but God will place friends along the way to 
enrich it, with companionships that will last. 
vi 
 
Table of Contents 
List of Figures…… ........................................................................................................................ ix 
List of Tables ...................................................................................................................................x 
List of Symbols and Abbreviations................................................................................................ xi 
Abstract ........................................................................................................................................... 2 
CHAPTER 1 Introduction............................................................................................................... 3 
CHAPTER 2 Literature Review ..................................................................................................... 7 
2.1 The Importance of Nutrition on Poultry Performance and Health .................................... 7 
2.1.1 Phase feeding broiler diets ....................................................................................... 8 
2.2 Antimicrobial Drug Usage ................................................................................................. 9 
2.2.1 Concerns over antimicrobial growth promoters .................................................... 11 
2.2.2 Alternatives to antimicrobial growth promoters .................................................... 12 
2.3 Medicinal Mushrooms ..................................................................................................... 13 
2.3.1 Medicinal mushrooms and poultry health ............................................................. 14 
2.3.1.1 Lentinus edodes (shiitake) ........................................................................... 17 
2.3.1.2 Ganoderma lucidum (reishi) ....................................................................... 18 
2.3.1.3 Pleurotus ostreatus (pleurotus) ................................................................... 19 
2.4 Poultry Immunity ............................................................................................................. 19 
2.4.1 Innate immunity ..................................................................................................... 20 
2.4.1.1 Innate immune cells..................................................................................... 20 
2.4.1.2 Acquired immunity ..................................................................................... 22 
2.4.1.3 Antibodies ................................................................................................... 23 
2.4.2 Gastrointestinal tract and immunity ...................................................................... 23 
vii 
 
2.5 Coccidiosis in Poultry ...................................................................................................... 25 
2.5.1 Etiology and epidemiology .................................................................................... 25 
2.5.2 Eimeria spp. affecting poultry ............................................................................... 26 
2.5.3 Clinical signs and symptoms ................................................................................. 27 
CHAPTER 3 Methodology ........................................................................................................... 28 
3.1 Animal Husbandry and Experimental Design ................................................................. 28 
3.2 Fungus Myceliated Grain Preparation ............................................................................. 29 
3.3 Diet .................................................................................................................................. 29 
3.4 White Blood Cell Differential Counts ............................................................................. 30 
3.5 Enzyme-Linked Immunosorbent Assay .......................................................................... 31 
3.5.1 Detection of chicken IgA and IgG concentrations ................................................ 31 
3.6 Eimeria Oocyst Counts .................................................................................................... 32 
3.7 Carcass and Bursa Weights ............................................................................................. 33 
3.8 Statistical Analysis ........................................................................................................... 33 
CHAPTER 4 Results and Discussion ........................................................................................... 34 
4.1 Body Weights .................................................................................................................. 34 
4.1.1 Unchallenged and challenged broiler body weight gain at 7 weeks (d 49) ........... 34 
4.2 Carcass Yield Percentages ............................................................................................... 36 
4.3 Mortality Percentages ...................................................................................................... 37 
4.4 Eimeria Oocyst Counts .................................................................................................... 38 
4.5 White Blood Cell Differential Counts ............................................................................. 40 
4.5.1 Heterophil counts ................................................................................................... 40 
4.5.2 Lymphocyte counts ............................................................................................... 42 
viii 
 
4.5.3 Monocyte counts ................................................................................................... 44 
4.6 Chicken IgA Concentrations ............................................................................................ 46 
4.7 Chicken IgG Concentrations ............................................................................................ 48 
4.8 Bursa Weights .................................................................................................................. 50 
CHAPTER 5 Summary and Conclusion ....................................................................................... 53 
5.1 Recommendations ............................................................................................................ 55 
References ..................................................................................................................................... 56 
  
ix 
 
List of Figures 
Figure 1 Effects of FMG Diet on Unchallenged Broiler Body Weights d 49 .............................. 34 
Figure 2 Effects of FMG Diet on Challenged Broiler Body Weights d 49 .................................. 35 
Figure 3 Effects of FMG Diet on Unchallenged Broiler Carcass Yields d 49 ............................. 37 
Figure 4 Effects of FMG on Eimeria oocysts Counts in Unchallenged Broilers d 49 ................. 39 
Figure 5 Effects of FMG on Eimeria oocysts Counts in Challenged Broilers d 49 ..................... 40 
Figure 6 Effects of FMG Diet on Heterophil % of Unchallenged Broiler d 49 ............................ 41 
Figure 7 Effects of FMG Diet on Heterophil % of Challenged Broilers d 49 .............................. 42 
Figure 8 Effects of FMG Diet on Lymphocyte % of Unchallenged Broilers d 49 ....................... 43 
Figure 9 Effects of FMG Diet on Lymphocyte % of Challenged Broilers d 49 ........................... 44 
Figure 10 Effects of FMG Diet on Monocyte % of Unchallenged Broilers d 49 ......................... 45 
Figure 11 Effect of FMG Diet on Monocyte % of Challenged Broilers d 49 .............................. 46 
Figure 12 Effects of FMG Diet on IgA Concentrations in Unchallenged Broilers d 49 .............. 47 
Figure 13 Effects of FMG Diet on IgA Concentrations in Challenged Broilers d 49 .................. 48 
Figure 14 Effects FMG Diet on IgG Concentrations in Unchallenged Broilers d 49................... 49 
Figure 15 Effects of FMG Diet on IgG Concentrations in Challenged Broilers d 49 .................. 50 
Figure 16 Effects of FMG Diet on Unchallenged Broiler Bursa Weights d 49 ............................ 52 
x 
 
List of Tables 
Table 1 Composition of Basal Meal Diets Provided by NCSU .................................................... 30 
Table 2 Mortality Percentages of Broilers on d 49 ....................................................................... 38 
 
  
xi 
 
List of Symbols and Abbreviations 
AA Amino Acids 
ANOVA Analysis of Variance 
AMGP Antimicrobial Growth Promoter 
AMR Antimicrobial Resistance 
β Beta 
BW Body Weight 
d Day 
C° Degrees of Celsius 
EPG Eggs Per Gram 
ELISA Enzyme-Linked Immunosorbent Assay 
EU European Union 
FE Feed Efficiency 
FMG Fungus Myceliated Grain 
GI Gastrointestinal 
GIT Gastrointestinal Tract 
GLM General Linear Model 
g Grams 
GALT Gut Associated Lymphoid Tissue 
HRP Horseradish Peroxidase 
hr Hour 
IgA Immunoglobulin A 
IgG Immunoglobulin G 
xii 
 
IACUC Institutional Animal Care and Use Committee 
kg Kilograms 
LSM Least Square Means 
µg Microgram 
µl Microliter 
ml Milliliter 
NRC National Research Council 
NCSU North Carolina State University 
PF Phase Feeding 
NANO₃ Sodium Nitrate 
spp. Species 
Trt Treatment 
USDA United States Department of Agriculture 
wk Week 
WBC White Blood Cell 
 
  
2 
 
Abstract 
A study was conducted to evaluate the effect of phase feeding a combination of 3 different 
medicinal mushrooms (Lentinus edodes, Ganoderma lucidum, Pleurotus ostreatus) via Fungus 
Myceliated Grain (FMG) on broiler performance and health after natural and experimental 
exposure to field strains of Eimeria. A total of 300, day-of-hatch, female broiler chickens were 
weighed and randomly assigned into the following dietary treatment conditions: 1) 1 % starter, 
2) 1 % grower, 3) 1 % starter-grower-finisher, 4) 5% starter, 5) 5% grower, 6) 5% starter-
grower-finisher, 7) 10% starter, 8) 10% grower and 9) 10% starter-grower-finisher. Each 
treatment was replicated 3 times with 10 chickens per replicate. Half the broilers in each 
treatment were challenged with a mixture of three pathogenic Eimeria spp. (E. acervelina, E. 
maxima and E. tenella) via oral gavage at 4 weeks of age. The body weights of broilers given 
FMG at the 1% inclusion level were significantly lower compared to broilers in the 5% and 10% 
starter phase. Eimeria counts for challenged broilers in the 5% grower phase were significantly 
higher than that of broilers given the 1% and 10% inclusion. Elevations in IgA and IgG levels 
were observed in the grower phase at the 1% level as well as the starter-grower-finisher phase at 
the 10% level. 
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CHAPTER 1 
Introduction 
Poultry production in the U.S. had increased significantly after the Second World War as 
the supply of beef and pork became limited (Food and Agriculture Organization (FAO), 2010). 
Prior to the war, the majority of poultry flocks were raised within the backyards of local farmers 
as a source of food for family consumption. Today, the commercial broiler industry has evolved 
greatly from backyard flocks into large-scale, high-density, mass production operations. Since 
the 1960’s, the consumption of chicken per capita has increased greatly from approximately 30 
lbs in 1965 to 80 lbs in 2012 (The National Chicken Council, 2012).The increase in broiler 
productivity reflects consumer demand based on preference for high-quality products at 
relatively low costs. At present, poultry is the number one meat consumed in the United States 
(The National Chicken Council, 2012). Internationally, the popularity of poultry meat is second 
only to that of pork (Best, 2011).  
Broiler meat is a healthy alternative to red meat, and is rated as one of the most important 
sources of animal protein in the world (Pan et al., 2012). Nutritionally, people consume broiler 
meat because it is high in protein, low in fat and it possesses an abundant source of almost all of 
the essential amino acids. Aside from their incredible nutritional value, broilers have one of the 
best feed to food conversion ratios of any other livestock species grown for meat (Aiello, 1998; 
Scanes, Brant, & Ensminger, 2004). Genetic selection for large meat producing birds along with 
the proper nutritional support provides producers with broilers that are able to reach market 
weight in excess of 4 pounds (1.8 kg) in as little as 7 weeks (49 days). The ability for broilers to 
grow quickly allows for shorter rearing periods and faster marketing production.  
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Feed is considered to be the most expensive aspect of poultry production. Therefore, it is 
essential to discover ways of reducing the cost of feed without compromising feed quality. In 
1997, Emmert and Baker reported a method of nutrient delivery referred to as phase feeding 
(PF). Phase feeding is a feeding regimen based off the nutritional requirements of broilers 
defined by the National Research Council (NRC) (1994). The nutritional needs of broilers 
decrease as the bird ages, therefore it is not necessary to maintain costly feed additives 
throughout the entire grow-out period. Since feed cost per meat yield is a main concern for 
broiler producers, it is essential that costs associated with broiler rearing remains relatively low. 
The PF nutritional system was designed as a precision feeding method for broilers that has the 
potential to decrease dietary costs by aiding in the improvement of feed efficiency (FE), growth 
potential¸ health and weight maintenance.  
Growth and productivity have always been important factors in the broiler industry. Most 
practical broiler diets are formulated with a mixture of the necessary nutrients to ensure 
maximum performance and good health. Proper nutrition aids in growth promotion, viability and 
the proper development of the immune system. Formulating diets for its effect on broiler 
intestinal health is becoming inevitable in the poultry industry. Many scientific studies suggest 
that nutrition and gut health are intricately correlated in broilers (Choct, 2009; Yang, Iji, & 
Choct, 2009). Therefore, diets can have a marked effect upon gut health and proper gut health 
greatly influences the nutrient utilization of feed thus improving weight gain.  
Any deterrent to broiler health can cause a decrease in profitability. The poultry industry 
is challenged frequently with the threat of infectious diseases that can alter productivity and 
diminish broiler well-being. Enteric diseases can be damaging to poultry productions due to 
increases in mortality, loss of productivity, decreases in efficient feed utilization and the 
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potential for human health risks that are linked to food borne illnesses. In addition, costs related 
to disease prevention and treatment can cause hefty reductions in profits. Coccidiosis is a 
common parasitic disease of poultry that causes considerable economic loss, especially in the 
production of broilers. The global economic impact of coccidiosis infections in poultry flocks is 
estimated to be about $3 billion annually (Bal, 2009). The incidence of coccidiosis in 
commercial poultry has increased considerably since the incorporation of intensive confined 
rearing conditions. The high density confinement methods of poultry rearing have favored the 
spread of this disease in commercial flocks worldwide. Intense focus has been placed on 
coccidiosis because of its significance in the poultry industry. 
Considerable steps have been taken in the field of poultry nutritional science within the 
last century in regards to improving both broiler feed and overall health. Antimicrobial growth 
promoters (AMGPs) have played an important role in the development of modern commercial 
poultry production. The addition of AMGPs in broiler diets at sub-therapeutic levels had, at one 
time, been the principal means of disease control in large commercial production flocks. 
However, antimicrobial feed additives can modulate some of the beneficial effects of the natural 
micro-flora found in the gut. In addition, exposing pathogens continuously to a low-dose of 
antibiotics can increase their resistance to these products. For these reasons, consumer demands 
have prompted new market niches for the poultry industry to deliver products that have a 
reduced risk of pathogens and are free of antibiotics and other drugs. 
Induced pressure over the concern of drug resistant organisms in poultry products has 
prompted investigations into the development of non-chemotherapeutic alternative feed additives 
(Apata, 2009). There are a plethora of studies that have been carried out in recent years on a 
variety of potentially health enhancing ingredients that could be incorporated into the diets of 
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poultry flocks for improvement of production and reduction of disease (Griggs & Jacob, 2005). 
One approach that has gained increased attention is the use of medicinal mushrooms as immune-
modulators. Mushrooms have been shown to possess medicinal properties that work to enhance 
the normal functions of the gut (Aida, Shuhaimi, Yazid, & Maaruf, 2009). The incorporation of 
medicinal mushrooms as natural feed additives in the basal diets of broilers may provide 
immune-enhancing properties against coccidiosis infection and other diseases, thus increasing 
growth and improving feed efficiency, intestinal integrity and overall performance (Hashemi & 
Davoodi, 2010). Medicinal mushrooms contain polysaccharides and other physiochemical 
properties that have been documented in broiler associated gut studies to improve the quality and 
quantity of the beneficial microbial flora that inhabit the gut (Guo et al., 2004b; Willis, King, 
Iskhuemhen, & Ibrahim, 2009). Enrichment of microbial activity has been directly associated 
with the enhancement of immunity, feed efficacy and general health in an organism (Isolauri, 
Sutas, Kankaanpaa, Arvilommi, & Salminen, 2001).  
The specific objectives of this study were to evaluate the overall influence of FMG 
placed into phase feed rations at different inclusion levels on the performance and health of 
broilers after natural and experimental exposure to field strains of Eimeria.   
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CHAPTER 2 
Literature Review 
2.1 The Importance of Nutrition on Poultry Performance and Health 
Proper nutrition is critical for both the health and well-being of broilers. Increasing 
awareness has placed emphasis on the link between nutrition, good health and proper immune 
function. This has prompted many commercial poultry producers to make health maintenance 
and disease prevention through diet a main priority in husbandry practices. To maintain health 
and productivity, broilers must be given a diet that completes their nutritional needs. This means 
supplying feed that incorporates all the basic nutrition in which a broiler will need to thrive 
throughout production. Nutrient efficiency in broilers is often obtained by using precision animal 
nutrition (PAN) (Sifri, 1997).  
Precision animal nutrition is a method of providing an animal with a diet that specifically 
meets its nutritional requirements (Sifri, 1997).  Providing diets based on PAN to broilers is 
necessary for optimal growth and development. However, PAN can be challenging to deliver as 
it is often difficult to target the precise nutritional requirements of an animal at specific stages of 
its life (Ferket, Van Heugten, Van Kempen, & Angel, 2002; Oviedo-Rondón & Waldroup, 
2002). For instance, nutritional needs for amino acids (AA) are reported to be the highest for 
broilers around 0-3 weeks of age (Emmert & Baker, 1997). Therefore, providing a singularly 
formulated, complete diet throughout the entire growth period can lead to nutritional excesses or 
deficiencies. The basic aim of precision nutrition is to alleviate the over and under feeding of AA 
in animal diets by supplying only what is necessary to meet the animals’ nutritional needs 
(Emmert & Baker, 1997). Since AA requirements can be influenced by a variety of dietary, 
genetic and environmental factors (Taherkhani, Shivazad, Zaghari, & Shahneh, 2008), many 
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different methods of precision feed delivery programs for broilers have been investigated 
(Makinde, 2013; Shariatmadari, 2009).  
2.1.1 Phase feeding broiler diets. In 1994, the NRC established a set of 
recommendations specific for meat producing poultry that involved feeding broilers nutrients 
according to their age and actively level. This proposal united the feeding regimen of both pullets 
and cockerels into three fixed periods of development: starter (0-3 weeks of age), grower (3-6 
weeks of age) and finisher (6-8 weeks of age) according to AA dietary needs (National Research 
Council, 1994; Warren & Emmert, 2000). This feeding regimen works on the principle of 
supplying growing broilers with a diet that is initially high in protein content which subsequently 
decreases as the bird matures and requires less protein and more energy for weight maintenance 
(Ewing, Pesti, & Bakalli, 2001).  
The body weights (BW) of commercial meat-type chickens increase rapidly within 6-8 
weeks post hatch (Toudic, 2006). Large amounts of AA are needed during this crucial period of 
growth to support the development of healthy muscle tissue (National Research Council, 1994). 
Proficient conversions of AA by broilers into breast meat during the grow-out period can boost 
carcass yields and decrease costs associated with feed. Since protein requirements for broilers 
decrease as the bird ages, it is not economically feasible to feed a diet that is fortified with high 
amounts of AA continuously throughout each stage of development (Dudley-Cash, 2004; Pope, 
Loupe, Pillai, & Emmert, 2004).  
Continuous  improvements in the genetic potential of meat birds coupled with 
innovations in dietary formulations in addition to the increased demand of varied broiler markets 
(Costa, Houston, Gunter, & Pesti, 2002; Swaggerty et al., 2009), have made the 
recommendations of the NRC for broiler diets nearly obsolete (Pope & Emmert, 2001, 2002; 
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Pope et al., 2004). The proposed regimen, set up nearly 20 years ago, no longer related to the 
grow-out periods of current commercial broiler operations (Warren & Emmert, 2000). It became 
necessary for researchers to consider revisions within the suggested feeding program of the NRC 
almost immediately after its proposal. In 1997, Emmert and Baker formally introduced phase 
feeding (PF) as a method of feed delivery that incorporated the NRC (1994) recommendations of 
precision nutritional requirements for broilers, yet allowed for variations in production times. 
Multiple studies involving modifications in PF programs have been conducted to fit the flexible 
amino acid requirements associated with modern broiler production systems (Emmert & Baker, 
1997; Pope et al., 2004). Phase feeding in broilers has also been utilized as a way to incorporate 
a variety of supplements and additives into feed for observation of their effects on overall health, 
performance and to reduce cost (Benites, Gilharry, Gernat, & Murillo, 2008; Driver, Pesti, 
Bakalli, & Edwards, 2006; Payne & Southern, 2005; Willis, Isikhuemhen, Hurley, & Ohimain, 
2011). At present, variations in PF methods have been universally applied to broiler production 
operations.   
2.2 Antimicrobial Drug Usage 
Antimicrobials have been used as additives in poultry feeds to reduce the occurrence of 
illness and to improve the utilization of feed for many years. These substances are either 
produced by microorganisms or synthetically manufactured and are used to kill or inhibit the 
growth of microbes such as bacteria, fungi, and protozoan (Schwarz, Kehrenberg, & Walsh, 
2001). Antimicrobials are generally differentiated into groups according to the microorganisms 
in which they specifically target. For instance, coccidiostats are a group of antimicrobial agents 
generally used to arrest the development of Eimeria, the causative agent of coccidiosis in poultry 
(McEwen & Fedorka-Cray, 2002); while bactericidal compounds commonly termed antibiotics, 
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destroy  potentially pathogenic bacterium that typically contaminate poultry such as Salmonella 
and  Escherichia coli (Kohanski, Dwyer, Hayete, Lawrence, & Collins, 2007). 
Antimicrobials used in livestock and poultry act primarily on the animal’s gastrointestinal 
(GI) micro-flora by modifying bacterial populations found within the gut (Yang et al., 2009). 
Detailed knowledge on the selective actions of antimicrobials on the intestinal bacteria of 
broilers are often absent within literature. However, it has been generally suggested that 
antimicrobials may aid in the integrity of the intestines by: protecting nutrients from bacterial 
degradation; reducing the amount of bacteria that naturally colonize the gut allowing for better 
digestibility and nutrient absorption; decreasing the amount of destructive toxins that these 
natural bacterium release and reducing the occurrence of intestinal infections (Butaye, Devriese, 
& Haesebrouck, 2003; Doyle, Bill, & Coffee, 2001).  
The use of antimicrobial agents as feed additives has played a major role in the successful 
growth and prevalence of the poultry industry. Commercial broiler industries adopted the use of 
antimicrobials in poultry feed as growth promoters shortly after their approval for use in 
agricultural animal feeds by the Food and Drug Administration (FDA) in the early 1950’s 
without the need of a prescription from a veterinarian (Jones & Ricke, 2003). Antimicrobial 
growth promoters describe compounds that are used at continuously low levels to improve 
animal growth and feed conversions while reducing the incidence of morbidity and mortalities 
(Butaye et al., 2003). They are generally administered to either prevent infections (sub-
therapeutic) or treat outbreaks of disease (therapeutic) (Schwarz et al., 2001). According to 
authors Piva and Rossi (1999), the sub-therapeutic use of antibiotics has the following aims: to 
serve as a prophylactic in young animals to help reduce the occurrence of enteric diseases and to 
prevent the onset of feed-induced pathogens in adults. Young broilers chicks (0-7 days of age) 
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are more susceptible to enteric pathogens since their immune systems are underdeveloped and 
naïve (Swaggerty et al., 2009). Older broilers have more established immune systems but are still 
vulnerable to a variety of enteric pathogens that can compromise the integrity of their health.  
The spread of infective pathogens is encouraged by the congested and stressful conditions 
under which most production animals are reared (Butaye et al., 2003). It had become necessary 
for commercial producers to incorporate ways of reducing the chance of disease outbreaks 
occurring in broiler flocks since infectious agents have the ability to reduce the carcass yields of 
production food animals resulting in economic losses. Consequently it had become, at one time, 
common practice for production animals such as broilers to be fed antimicrobials in their diets 
for the prevention of disease (McEwen & Fedorka-Cray, 2002).  
2.2.1 Concerns over antimicrobial growth promoters. AMGPs are not as celebrated 
today as they once were 60 years ago (Cook, 2004). The continuous use of antimicrobial drugs 
has promoted the emergence of multi-drug resistant strains of microbes (Apata, 2009). As a 
result, they are not considered as effective now as when they were initially introduced. The 
incidence of antimicrobial resistance (AMR) has led to a considerable amount of public distrust 
for food safety regarding broilers. High incidences of AMR among the pathogenic and 
commensal bacteria that populate poultry and frequency of resistant bacterial strains signify a 
great public health hazard (Apata, 2009). There are many retrospective and prospective studies 
that document the occurrence of resistant pathogens in broilers (Luangtongkum et al., 2006; Van 
den Bogaard et al., 2001; Van den Bogaard et al., 2002).  
An initial sign of resistance to AMGPs began with the usage of streptomycin in turkeys 
(Starr & Reynolds, 1951). This occurred shortly after antibiotics were approved for use as 
additives in production animals without the prescription of a veterinarian in the early 1950s. 
12 
 
Shortly thereafter, streptococci resistance to tetracycline had been reported in AMGP fed poultry 
(Barnes, 1958; Dibner & Richards, 2005). A couple years later, in 1969, the incidence of 
antimicrobial resistance had been reported by the Swann Committee, a division of the British 
government. The agency issued a report requesting to restrict the use of AMGPs that were used 
in both animal and human medicine, since the discovery of Salmonella enterica serovar 
Typhimurium resistance to oxytetracycline in food animals (Cogliani, Goossens, & Greko, 
2011). This event was one of the first to confirm the presence of resistant microbes observed 
globally. Since then, many regulatory changes have taken place to reduce the use of in feed 
animal AMGP additives by incorporating limitations and bans on the use of sub-therapeutic 
levels of antibiotics in production animal rations (Buchanan et al., 2008). For instance, the use of 
penicillin and tetracycline as AMGPs were banned in the United Kingdom in the 1970’s (Hughes 
& Heritage, 2004).  Sweden and Denmark banned the use of antimicrobials as AMGPs in 
production animal feed entirely in 1986 and 1999 (Aarestrup et al., 2001; Wierup, 2001). And 
the United States followed suit by banning the use of enrofloacin in 2005 (Buchanan et al., 2008; 
Revington, 2003). 
2.2.2 Alternatives to antimicrobial growth promoters. The overuse of antimicrobials 
can lead to the disruption of the normal micro-flora of the gut which allows pathogens to breach 
and overwhelm the hosts’ immune system (Cervantes, 2008). In addition, the rapid development 
of multi-drug resistant pathogens, increasing consumer pressure for a more natural and less 
chemically enhanced food, as well as regulatory change has prompted researchers to search for 
alternative solutions (Noirot, 2010). According to literature, there are three basic strategies that 
can be used to cope with the loss of AMGPs, they are: 1) pathogen reduction; 2) augmentation of 
the immune response and; 3) nutritional strategies and/or additives that either improve 
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performance, or aid in the production of beneficial gut microbial flora (Ferket, 2003; Ferket, 
2004; Revington, 2003). 
Several natural feed additives have been investigated as sources of potential immune-
modulatory dietary additives in poultry (Allen & Fetterer, 2002). For example essential oils, 
organic acids, and phytogenic compounds have been shown to enhance production of gastric 
secretions, stimulate blood circulation, and reduce levels of pathogenic bacteria (Buchanan et al., 
2008). Findings by investigators Buchanan et al. (2008) suggest that formic, acetic, and 
propionic acids reduce the prevalence of Salmonella and Campylobacter bacteria found in the 
intestines of broilers. In recent years, an innovative approach to broiler health enhancement and 
immune system enrichment has involved the use of medicinal mushrooms incorporated into 
broiler diets via feedstuffs or extracts (Giannenas et al., 2010; Guo et al., 2004a; Willis et al., 
2008; Willis, Isikhuemhen, & Ibrahim, 2007). 
2.3 Medicinal Mushrooms 
Mushrooms have been used as a food source by many cultures worldwide since antiquity 
(Chang & Miles, 2004). Nutritionally, mushrooms are a nearly perfect food. Studies have 
indicated that several edible forms of fungi are rich in carbohydrates, vegetable proteins, 
essential amino acids, dietary fibers, vital vitamins and minerals (Garcha, Khanna, & Soni, 1993; 
Lakhanpal & Rana, 2005; Manzi, Gambelli, Marconi, Vivanti, & Pizzoferrato, 1999). In addition 
to their nutritional importance, several mushrooms have long been recognized for having 
medicinal properties. One such genre of fungi, Basidiomycetes, are described as a class of  
higher fungi whose members have fleshy, macro-fungi, are both edible (Agaricus) and non-
edible (Amanita), and are rich in bioactive compounds (Hobbs, 1995; Madigan, Martinko, & 
Brock, 2006 ).  
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The majority of basidiomycetes produce visible fruiting bodies in addition to a mass of 
hyphae generally referred to as mycelium, which constitutes the vegetative part of the fungus. 
The fruiting bodies of basidiomycetes are reproductive structures that produce spores and are 
generally viewed growing above ground (Cheung, 2008; Hobbs, 1995). The mycelia are complex 
networks of filamentous hyphae that grow within a medium such as wood, feed grains or ground 
soil (Madigan et al., 2006 ). The mycelia secrete strong enzymes into the environment in which it 
colonizes and breaks down complex carbohydrates into simpler sugars in which it uses to nourish 
itself (Hobbs, 1995; Marley, 2009). Both the fruiting bodies and mycelium of basidiomycetes 
have been used as a functional food source (Cheung, 2008). Basidiomycetes have an extensive 
history in folk medicine, specifically Traditional Chinese Medicine and have been incorporated 
into modern medicines and medical practices as a way to promote health (Wasser & Weis,1999).  
2.3.1 Medicinal mushrooms and poultry health. In recent years, advances in scientific 
and medical research have prevailed in the identification, isolation, purification and effective use 
of several bioactive molecules found in medicinal mushrooms (Smith, Rowan, & Sullivan, 
2002). Basidiomycetes contain biologically active polysaccharides such as beta-glucans, lectins, 
and terpenoids in the cell walls of their fruiting bodies and mycelium (Wasser, 2011). The 
bioactive polysaccharides, particularly β-glucans, found in these fungi vary in chemical 
composition and have been shown to possess strong immunomodulation behavior (Horowitz, 
2011; Wasser, 2002). Constituents of basidiomycetes are reputed to possess; antitumor, anti-
cholesterol, antibacterial, antiviral, anti-diabetic, anti-allergic and anti-parasitic properties 
(Dalloul, Lillehoj, Lee, Lee, & Chung, 2006; Wasser & Weis, 1999).  
There is increasing evidence that mushrooms may play a major role in the immune-
enhancement of poultry. Information regarding the use of mushrooms as a way to promote 
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performance and health in chickens, however, is limited. However, there are some scientific 
reports that do attest to the administration of fungi to enhance the overall productivity and health 
of poultry (Dalloul et al., 2006; Guo, Savelkoul, Kwakkel, Williams, & Verstegen, 2003). 
Mushrooms have been known to have a natural prebiotic effect on the gastrointestinal 
environment of many organisms including poultry. The oral consumption of fungi can encourage 
the stimulation of the microbiological ecosystem within in gut, resulting in immunity 
enhancement.  
An in vivo study conducted by Guo et al. (2004b) evaluated the potential effects of the 
shiitake mushroom extract along with other natural products on chicken growth and the integrity 
of the cecal ecosystem. In this study, the shiitake mushroom extract was compared against that of 
a well-known anticoccidicial agent, apramycin. Chickens were naturally infected with avian 
Mycoplsma gallisepticum, an economically significant pathogen in poultry, prior to the study. 
Results concluded that both the shiitake extract and apramycin significantly stimulated the 
growth of chickens although the body weights of the birds given extracts were significantly 
lower than those given apramycin. However, birds who received the shiitake extract were found 
to have a higher population of beneficial bacteria within the ceca compared to those given 
apramycin (Guo et al., 2004b). This suggests that the bioactive compounds found within the 
mushroom extract may have the potential to positively influence the growth of beneficial 
intestinal micro-flora in diseased birds. A study conducted by Willis et al. (2009) also suggested 
the advantageous effects of mushroom extracts given to chickens on the positive influential 
growth of beneficial microbial populations within the intestines. In this study, the effects of 
administrating shiitake (L. edodes) mushroom extract on broiler intestinal bifidobacteria and 
Salmonella bacteria populations were evaluated. Findings from this study found that the 
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supplementation of mushroom extracts in broiler diets aided in increasing populations of 
bifidobacteria while suppressing the growth of potentially pathogenic Salmonella populations. In 
another study by Willis et al. (2007) the continual shedding of beneficial bacteria in broiler feces 
was reported after the administration of shiitake mushroom extract. This may indicate that the 
bioactive components of the shiitake mushroom extract enhanced conditions within the intestines 
allowing for greater bifidobacteria proliferation. Dietary extracts from the shiitake mushroom 
have also been found to improve egg production in layer hens while reducing the Salmonella 
bacterial populations during molt (Willis et al., 2008).  
Dalloul et al. (2006) reported a study incorporating the use of fungi in poultry feed. In 
this experiment, a lectin extracted from the F.  fraxinea mushroom was given to chickens orally 
challenged with Eimeria. The goal of this study was to evaluate the effect of the F. fraxinea 
mushroom extract on poultry immunity against coccidiosis. The investigators found that the F. 
fraxinea extract produced a strong proliferative response in lymphocytes and significantly 
protected chickens against weight loss associated with coccidiosis. Scientific studies regarding 
the use of mushrooms incorporated into chicken fed via FMG utilized for their prebiotic effects 
on chicken performance and immunological health have been reported by Willis et al. (2009, 
2010a, 2010b, 2012 & 2013). These studies collectively demonstrated benefits from the 
inclusion of mushrooms into the diets of broilers and laying hens by preferentially improving 
body weights, increasing beneficial bacterial populations, reducing the fecal shedding of Eimeria 
oocysts and decreasing the population densities of potentially pathogenic Salmonella bacteria.  
The relationship between intestinal health and overall immunity in chickens has been reported by 
several authors. For example, Guo et al. (2004c) demonstrated the immune enhancement of E. 
tenella infected chickens fed diets supplemented with mushrooms and herb extracts. Selegean et 
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al. (2009) investigated the use of extracellular fractions containing polysaccharides from the P. 
ostreatus mushroom on its ability to stimulate the immune systems of broilers and its potentially 
synergistic relationship with conventional poultry vaccines against the Infectious Bursal Disease 
virus, during the first two weeks post hatching. The use of mushroom components as 
immunomodulators in poultry water and feed have shown promising results suggesting that the 
use of medicinal mushrooms may be one way of creating immune-competence in poultry with an 
approaching post-antibiotic era.  
2.3.1.1 Lentinus edodes (shiitake). Shiitake is an amber colored mushroom that has long 
been a symbol of prosperity and longevity in traditional Asian culture. This species of edible 
fungus is indigenous to Eastern Asia and can be found growing on the wood logs of a variety of 
native deciduous trees to include that of the shii tree (Castanopsis cuspidate), in which the 
shiitake mushroom is partially named (Wasser, 2005). Shiitake is one of the 5 most cultivated 
edible fungi worldwide, being second only to Agaricus bisporus, the button mushroom (Chang & 
Miles, 2004; Jones, 1998; Wasser, 2005). Shiitake, nicknamed the “monarch of mushrooms”, is 
well-known for its high nutritional value and health benefits. It is a nutritionally sound, flavorful 
food containing a high percentage of water, proteins, lipids, enzymes, carbohydrates, vitamins 
and minerals (Hobbs, 1995; Wasser, 2005). Extracts and dried whole products of the mushroom 
are often used in herbal remedies (Stengler, 2005). Shiitake gained its popularity particularly for 
its medicinal properties after extensive scientific investigational studies revealed its ability to 
regulate chronic health conditions such as hypertension, cardiovascular disease and diabetes 
(Broadhurst, Polansky, & Anderson, 2000; Chen & Raymond, 2008; Houston, 2005). 
Components of the shiitake mushroom have been used in the treatment of ulcers, allergies and 
parasitic infections (Bilay et al., 2011; Jones, 1995). Additional studies using shiitake have 
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publicized the mushroom’s antitumor, immunostimulatory, and antiproliferative properties 
(Borchers, Keen, & Gershwin, 2004; Kaneno et al., 2004; Wasser, 2005).  
Eritadenine, found in the mycelia and fruiting body of shiitake, have been found to 
dramatically reduce the blood cholesterol of rats that had received diets high in cholesterol 
(Shimada, Morita, & Sugiyama, 2003). A polysaccharide called lentinan, also isolated from the 
shiitake mushroom, has been shown to regress tumors in mice experimentally infected with 
aggressive cancers (Vetvicka & Vetvickova, 2012). Shiitake has also been found to contain a 
substance called cortinelin, a broad spectrum antibacterial agent (Carvalho, Van Der Sand, Rosa, 
Germani, & Ishikawa, 2008). The administration of shiitake extract to broilers has been shown to 
reduce pathogenic Salmonella infections (Willis et al., 2009). The shiitake mushroom has a 
relatively low toxicity and has been reported to be tolerated well by both humans and animals in 
health related studies (Hobbs, 1995).  
2.3.1.2 Ganoderma lucidum (reishi). Ganoderma lucidum, commonly known as Reishi, 
is a woody mushroom that is commonly known for parasitizing the wood of trees and causing 
them to decay. The mushrooms’ cap is distinctively kidney-shaped and reddish in color. For 
centuries, the Reishi mushroom has been highly regarded as one of the best known and well 
characterized medicinal mushrooms due to its wide variety of biological activities. Reishi is 
regarded as the “plant of immortality” in Asian culture because of its many health benefits and 
extended usage in Chinese, Japanese and Korean medicine (Meschino, 2002). Beneficial 
compounds of the Reishi mushroom include β-glucans, triterpenes, sterols, lactones, vitamins 
and minerals (Hobbs, 1995). These compounds work by stimulating the immune system and 
increasing the amount of active cells and thus the potential for their effects. It has been reputed to 
possess antitumor, immunomodulatory, cardiovascular, respiratory, hepatoprotective, antitumor 
19 
 
and anti-inflammatory properties (Chang & Miles, 2004; Zhu, Chang, Wong, Chong, & Li, 
1999).  
2.3.1.3 Pleurotus ostreatus (pleurotus). Pleurotus is commonly called the oyster 
mushroom because its fleshy pileus is generally white and semi-circular resembling that of an 
oyster shell (Hobbs, 1995). Pleurotus grows in clusters on the wood of deciduous trees. It can be 
found growing in parts of Asia, Europe and North American and is cultivated in many parts of 
the world. Pleurotus has a high nutritional content and contains many essential amino acids and 
vitamins (Hobbs, 1995). The active compounds of the oyster mushroom include polysaccahrides, 
lectins, peptides, lovastatin-type compounds and ergosterols. 
2.4 Poultry Immunity  
Intense poultry production systems with densely populated flocks, under which most 
commercial broilers are raised, can cause birds to endure a great deal of undue stress (Kabir, 
Rahman, Rahman, & Ahmed, 2004). Stress, generally defined as a physical, chemical, or 
emotional factor that causes bodily or mental strain, may be a causative factor of disease 
(Heritage, 2005; Pease, 2006). Health issues in the poultry industry can be induced by a 
combination of stressful factors including: stress induced by improper management, nutritional 
stress, environmental stress, physiological stress and pathological stress (Downing & Bryden, 
2002; Hill, 1983; Rosales, 1994; Siegel, 1980; Tankson, Vizzier-Thaxton, Thaxton, May, & 
Cameron, 2001). Confinement rearing coupled with higher bird densities have increased flock 
risks of exposure to various protozoal, bacterial, viral and fungal pathogenic agents via feed, 
water, air, litter and direct contact with other birds (Kogut, 2009; Yegani & Korver, 2008).  
For many pathogens, the avian body is a nearly ideal habitat as it offers protection from 
outside elements, a ready source of nutrients, and is a means for transmission to new hosts and 
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environments (Campbell & Reece, 2008). Chickens have developed a sophisticated immune 
system similar to that of mammals that is capable of defending the bird against a broad spectrum 
of disease causing pathogens (Korver, 2006). The two primary functions of the avian immune 
system are recognition and response (Kindt, Goldsby, & Osborne, 2006 ). Defense mechanisms 
in chickens include both nonspecific (innate) and specific (acquired or adaptive) immune 
responses. These systems work together to combat potential threats from bacteria, viruses, 
parasites and other foreign antigenic material. Innate and adaptive immunity are considered 
essential factors for the survival and health of the host. 
2.4.1 Innate immunity. In the chicken, innate immunity is composed of both barrier 
defenses (feathers, skin, and mucosal linings), as well as cellular defenses that are activated 
immediately following exposure to pathogens. Leukocytes or white blood cells (WBC) provide a 
non-specific immunological defense to the host (Qureshi, Hussain, & Heggen, 1998). 
Granulocytes, macrophages and other innate immune cells all play a major role in pathogenic 
recognition and elimination. These cells inactivate foreign biological agents directly by lysis, 
agglutination, or phagocytosis (Hub, 2011).  Avian innate immunity is found to be functional at 
hatch and development continues to occur throughout the first week of a birds life (Dibner et al., 
1998; Korver, 2006).  
2.4.1.1 Innate immune cells. Granulocytes are polymorphonuclear luekocytes (PMN) 
that have secretory granules in their cytoplasm. Avian granulocytes include heterophils, 
eosinophils and basophils (Thrall, Weiser, Campbell, & Allison, 2004). Heterophils are one of 
the most abundant granulated leukocytes in the avian body and are documented to be highly 
efficient in phagocytosis and bacterial inhibition (Weiss & Wardrop, 2010). Avian heterophils 
are functionally similar to mammalian neutrophils although they differ morphologically and 
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biochemically (Swaggerty et al., 2009). Heterophils have been shown to increase in number at 
sites of acute inflammation and during long periods of induced stress (Davis, Maney, & Maerz, 
2008; Swaggerty et al., 2009). Using artificial irritants, some investigators have been able to 
illustrate the influx of heterophils during the acute phase of inflammation in broilers. Brickford 
(2007) suggests that heterophil numbers may increase due to inflammation, stress, infection and 
tissue damage. 
Not much is known about the general functions of both the avian eosinophil and basophil 
(Thrall et al., 2004). The mammalian eosinophil, on the other hand, is well documented and has 
been described to have the ability to form protection against helminthic infestations, and is 
frequently associated with allergic responses (Machnicka-Rowińska & Dziemian, 2003). Studies 
using parasitic antigens and other stimulants in an attempt to induce peripheral eosinophilia in 
birds have proven rather unsuccessful (Maxwell, 1980; Maxwell & Burns, 1981; Maxwell & 
Burns, 1986) although eosinophilia had been reported in studies involving gastrointestinal 
nematode infestations (Thrall et al., 2004).  
Avian basophils contain histamine, as do their mammalian counterparts, which suggest 
that they may play an important role in inflammation and hypersensitivity reactions (Chand & 
Eyre, 1978; Maxwell & Robertson, 1995; Mitchell & Johns, 2008). According to information 
reviewed by Weiss and Wardrop (2010), both clinical and experimental evidence suggests that 
the avian basophil may have some involvement in host response to internal and external 
parasites. Though basophilia in birds is said to be rare it has been reported in respiratory disease, 
clamydiosis infections and in trauma to tissue (Doneley, 2010). Additionally it is assumed that 
these leukocytes participate in the initial phase of acute inflammation and may be associated with 
a stress response in birds (Maxwell, Robertson, Mitchell, & Carlisle, 1992; Thrall et al., 2004).  
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Avian monocytes are the largest leukocyte in avian peripheral blood and they are 
functionally similar to mammalian monocytes. Monocytes in general, perform phagocytic 
activities and transform into macrophages after migration into various body tissues. Monocytes 
are often associated with acute infectious or chronic inflammatory responses (Mitchell & Johns, 
2008). An influx of monocytes is often observed in both infectious and inflammatory diseases 
(Qureshi, 2003). After monocytes develop into tissue macrophages, they become capable of 
degrading and presenting antigenic peptides to immune lymphocytes thus activating the acquired 
immune system (Mitchell & Johns, 2008; Qureshi, 2003).  
When the physical barriers of the innate immune system are breached, these immune 
cells work both directly and indirectly on disabling the invading microbe. If infection persists, 
the bird’s innate immune responses utilize antigen presentation and cellular signaling to activate 
the acquired immune response.  
2.4.1.2 Acquired immunity. Humoral immunity is the acquired function of the immune 
system through which antibodies are produced in response to an antigenic challenge (Qureshi et 
al., 1998). These antibodies are produced in response to foreign antigenic stimuli by modified B 
lymphoctyes (B-cells). B-cells originate in the bursa of Fabricus, a primary lymphoid organ that 
is unique to the avian species. The Bursa of Fabricius is a small, hollow, sac like organ that is 
connected to the cloaca, an excretory organ in birds (Glick, 1979).  The bursa is the site of B cell 
differentiation and maturation. After B-cells have fully matured, they are released from the bursa 
to circulate within the blood and lymphatic fluids. B-cells that are exposed to and stimulated by 
foreign antigen within the body will either develop into memory cells or differentiate into 
specialized lymphocytes called plasma cells (Brand, Gilmour, & Goldstein, 1976). Memory B-
cells have a prolonged life span and are capable of "remembering” specific pathogens. Plasma 
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cells produce and secrete cell surface soluble proteins known as immunoglobulin (Ig) or 
antibodies (Tizard, 2002).  
2.4.1.3 Antibodies. Antibodies are glycoproteins that are used by the immune system to 
identify and neutralize foreign microbes. Two major antibody isotypes found in poultry include; 
immunoglobulin G (IgG), and immunoglobulin A (IgA) (Tirziu & Ere, 2010; Tizard, 2002). 
Avian antibodies differ slightly from that of mammalian antibodies by way of structure and 
function although they are predominantly homologues. 
Avian IgG, sometimes termed IgY, are similar to both mammalian IgG and IgE 
functionally. Avian IgG is often referred to as IgY because specific studies have shown that it 
differs both structurally and biochemically from that of mammals. Therefore, IgG and IgY are 
generally used interchangeably in literature. Avian IgG is the predominant antibody produced 
against established and systemic infections (Perry, 2006; Scanes et al., 2004).  
The avian IgA function is similar to mammalian IgA.  It is the predominant antibody 
found in bodily secretions and is the major antibody found within the intestinal tract. Antibodies 
are an important component of the acquired immune system as they provide antigen-specific 
immunity to extracellular pathogens. An increase in circulating antibodies within the blood or 
lymphatic fluids can suggest infection within the body.  
2.4.2 Gastrointestinal tract and immunity. Gastrointestinal immunity is perhaps the 
most important aspect of the avian immune system. The primary role of the gastrointestinal tract 
(GIT) in any animal is to digest and absorb nutrients in order to meet the demands for normal 
growth and development (Isolauri et al., 2001). The GIT also functions as a barrier against 
pathogens from micro-organisms. The intestinal mucosa lining of the GIT provides a protective 
layer of defense against the constant presence of antigens from food and micro-organisms in the 
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gut lumen. Isolauri et al. (2001) reported that the protection against potentially harmful agents is 
ensured by many factors, this includes saliva, gastric acid, peristalsis, mucus, intestinal 
proteolysis, intestinal flora, and epithelial cell membranes. The micro-flora of the GIT is a 
mixture of beneficial bacteria, fungi and other protozoa that work symbiotically with the host in 
creating homeostasis in the intestinal tract. Intestinal micro-flora has been shown to have these 
beneficial effects on the body: vitamin production, stimulation of the immune system through 
nonpathogenic mechanisms, and inhibition of the growth and establishment of harmful micro-
organisms (Yegani & Korver, 2008). The mucosal surface of the gut is one of the primary 
pathogen portals of entry to the bird (Korver, 2006). For example, avian enteric diseases such 
Eimeria gain entry to a bird through the alimentary tract where they proliferate and cause severe 
tissue damage resulting in host morbidity or mortality. Therefore, the immune responses of the 
GIT must be able to combat such infectious agents without disturbing the homeostasis and 
normal physiological activities of the gut.  
The GIT is composed of the gut associated lymphoid tissue (GALT), one of the largest 
secondary lymphoid organs in the body. The GALT is composed of several types of immune 
cells and tissue and is essential for protection of the host against invasion from pathogenic 
organisms. Pathogens entering the GIT become trapped in the mucosa where they are inactivated 
by secreted GALT components such as IgA (Kindt et al., 2006 ; Korver, 2006). As a result the 
inactivated microbes are unable to colonize the gut and are therefore passed out of the digestive 
tract. In this way the GIT is able to control the presence and absorption of antigens within the 
intestine. Many reports have suggested that the key to keeping chickens immuno-competent is by 
the proper management of the GIT (Kidd, 2004).  
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2.5 Coccidiosis in Poultry  
Adverse effects on the GI tract can cause major economic losses. Such is the case with 
avian coccidiosis, a prevalent and severe enteric infection of poultry. Coccidiosis affects many 
different species of animals and is of great economic significance in livestock and poultry. 
Coccidiosis is one of the most prevailing diseases affecting the U.S. broiler industry with 
estimated annual total cost resulting in millions dollars (Allen & Fetterer, 2002; David Chapman, 
2003; Chapman, 2009; Dalloul & Lillehoj, 2005; Noirot, 2010). Contribution to losses are 
attributed by the costs of in-feed chemotherapeutic prophylactics (growth promoters), therapeutic 
treatments if the application of growth promoters prove unsuccessful and losses due to 
morbidity, mortality, inefficient feed utilization, poor feed conversion and impaired growth rates 
(Allen & Fetterer, 2002; Badran & Lukesová, 2006; Dalloul & Lillehoj, 2005).  
2.5.1 Etiology and epidemiology. Coccidiosis is one of the most prevalent parasitic 
diseases of broilers. It is generally described as an acute, intracellular parasitic disease that 
primarily affects the intestinal tract of the host often resulting in morbidity, impaired growth and 
poor feed utilization. Avian coccidiosis in poultry is caused by single-celled parasitic protozoan 
of the genera Eimeria (Boughton, 1937; Cervantes, 2008; Fanatico, 2006). These parasites, 
belonging to the sub-kingdom Protozoa and to the phylum Apicomplexa (Aiello, 1998), are 
predominantly host specific and are generally characterized by their replication in host cells as 
well as their ability to cause extensive damage to the intestinal lining (Aiello, 1998; Conway & 
McKenzie, 2007). 
 Coccidia are ever present in poultry-rearing operations and are generally found in the 
intestines of mostly young birds that are 3 weeks of age or older (Damerow, 1994). Coccidia are 
transmitted to healthy chickens that ingest oocysts that have been shed in the feces of infected 
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chickens. Gradual exposures to small amounts of Eimeria in the environment allow young chicks 
to gain a natural resistance to these pathogens over a period of time. In such cases flocks may 
only have mild or subclinical infections where they exhibit little to no clinical signs, this is 
referred to as coccidiasis (Aiello, 1998; Conway & McKenzie, 2007; Damerow, 1994). Clinical 
disease generally manifests when birds are exposed to excessive amounts of Eimeria within their 
environment (Damerow, 1994).  
In a recent review, Conway and McKenzie (2007) suggest that exposure to active 
Eimeria oocysts usually begins shortly after day old chicks are placed onto poultry house litter. 
Litter oocysts counts are generally low during the first 2 to 3 weeks of placement but tend to 
increase rapidly at 4 to 6 weeks and decrease again to low levels by 7 and 8 weeks. This pattern 
of infection indicates that coccidiosis infections are more likely to occur in broiler chicks at 3 to 
6 weeks of age (Chapman, 1984; Conway & McKenzie, 2007).  Birds raised in high density 
flocks are at greater risk for developing coccidiosis as they are more likely to become stressed 
(Damerow, 1994). As stated previously, flocks are vulnerable to the rapid spread of infectious 
agents and disease outbreaks under intense rearing conditions. Scientific reports by both Badran 
et al. (2006) and Noirot (2010) suggested that the pathogenicity of Eimeria in poultry flocks is 
influenced by and often a result of an imbalance between: 1) the parasites in relation to their 
numbers and infectivity, 2) the host in relation to its susceptibility, natural and acquired 
resistance and ability to recover from infection and 3) the rearing environment in relation to 
proper management techniques. 
2.5.2 Eimeria spp. affecting poultry. In  broiler chickens there are seven (Schnitzler, 
Thebo, Mattsson, Tomley, & Shirley, 1998) species of Eimeria that have been described in 
literature; Eimeria acervulina, Eimeria praecox, Eimeria maxima, Eimeria mitis, Eimeria 
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necatrix, Eimeria tenella, and Eimeria brunette (Aiello, 1998; Cervantes, 2008; Chapman, 1978; 
David Chapman, 2003; Schnitzler et al., 1998). Of these species, however, only three; E. 
acervulina, E. maxima and E. tenella have been widely recognized as being the most pathogenic 
(Aiello, 1998; Cervantes, 2008; Fanatico, 2006).  
2.5.3 Clinical signs and symptoms. Most chickens are exposed to and parasitized by 
more than one species of Eimeria, with mixed infections found frequently in the field (Cervantes, 
2008). Collectively, all species of avian Eimeria are capable of producing morbidity in broilers 
with their pathogenicity varying from mild to moderate and very severe.  Altogether signs and 
symptoms can include; reduced pigmentation, severe bloody diarrhea, dehydration, impaired 
growth, lethargy, depression, drooping and suppressed appetite. Other recognizable signs include 
poor feed utilization, lowered feed intake, impaired weight gain, weight loss and mortality in 
severe cases (Fanatico, 2006; Noirot, 2010). Birds that are able to recover from infection may 
never regain their productivity and therefore may have to be culled. Birds that recover and regain 
productivity and those that harbor sub-clinical infections may serve as permanent reservoirs of 
infection. 
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CHAPTER 3 
Methodology 
3.1 Animal Husbandry and Experimental Design 
This study was performed to evaluate the effects of dietary medicinal mushrooms on the 
immunity, coccidiosis control, general health, product safety and overall performance of broiler 
chickens utilizing three different inclusion levels at specific grow-out phases. This trial was 
performed at the Poultry Research Farm at North Carolina Agricultural and Technical State 
University located in Greensboro, NC. The treatment, housing, handling, management and 
humane euthanasia of subjects confirmed to all rules and regulations set by the Institutional 
Animal Care and Use Committee (IACUC).  
A total of three hundred, day-of-hatch, female (Ross x Ross) broiler chicks were obtained 
from a local commercial hatchery (Siler City, NC). All chicks were vaccinated against Newcastle 
disease, infectious bronchitis and Mareks’s disease prior to release from the hatchery. No form of 
coccidiosis protection was provided. The chicks were divided into groups, weighed and 
randomly assigned to one of the following dietary treatment conditions: 1) 1 % starter, 2) 1 % 
grower, 3) 1 % starter-grower-finisher, 4) 5% starter, 5) 5% grower, 6) 5% starter-grower-
finisher, 7) 10% starter, 8) 10% grower and 9) 10% starter-grower-finisher. Each treatment 
condition was replicated a total of 3 times with 10 chicks per replicate.  
Birds were housed in floor pens, one for each replicate treatment group, on unused litter 
with one hanging tube feeder and one drinker per pen. The lighting program was set to be 
continuous throughout the trial. The temperature was maintained at 35° C at the start of the trial 
and reduced weekly thereafter until reaching 24°C. Tunnel ventilation was set on an automatic 
periodic cycle timer and provided adequate air flow conducive for poultry rearing.  
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At 28 d of age, half the birds in each treatment replicate group challenged with a mixture 
of three pathogenic Eimeria spp. strains; E. acervulina, E. maxima and E. tenella. via oral 
gavage. Each experimental subject was challenged via oral gavage with 1 ml of a 49,000 
oocysts/ml suspension solution. Mortalities were evaluated and recorded daily. Birds were 
weighed in groups according to their corresponding treatments using a standard industrial scale. 
Blood samples were collected from broilers for WBC differential count analysis. Fecal sampling 
for oocysts counts were taken on d 49. The IgG and IgA antibody concentrations, carcass and 
bursa organ weights for each treatment group were recorded at the conclusion of the trial (d 49). 
3.2 Fungus Myceliated Grain Preparation  
Shiitake, Reishi and Pleurotus mushrooms were cultivated at the Mushroom Biology and 
Fungal Biotechnology Laboratory at North Carolina Agricultural and Technical State University 
Farm (Greensboro, NC). At the laboratory, sorghum (white milo), a common cereal grain used in 
the poultry industry, was soaked in water overnight and drained the following day. Five 
kilograms of the sorghum grain was loaded into individual micropore fitted bags (Unicorn Mfg 
Co. Texas, USA). The bags were sterilized at 121°C for 3 h. Afterwards the sterilized grain was 
individually inoculated with L. edodes, G. lucidum and P. ostreatus mycelium and incubated at 
25°C for 2 wk before use. The individual medicinal mushroom and grain biomass conjugant 
were transported to the Poultry Research Center at NCAT where they were dried. The compound 
grain was then ground into a powder that was used as a supplement in the basal meal dietary 
ration in each treatment.  
3.3 Diet 
Broilers in all treatment groups were fed a basal starter (1-14 d), grower (15-28 d) and 
finisher (29-49 d) diet in correspondence with modified grow-out phases. The basal diets were 
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supplemented with a 1%, 5% and 10% FMG medicinal mushroom mixture consisting of a 
combination of Shiitake, Reishi and Pleurotus. The supplemented diets were then administered to 
the individual treatment groups during their respective stages of development in correspondence 
with the treatment design. Feed and water, both free of drugs and medications, were provided to 
all treatment groups ab libitum.  
Table 1  
Composition of Basal Meal Diets Provided by NCSU 
                       Ingredients  Amount  
 Starter Grower Finisher 
Corn 1167 1324 1410 
Soybean meal 716 563 478 
Corn micro-flush 19.94 20.73 20.30 
Limestone fine 19.42 20.40 21.37 
Dicalcium phosphate (18.5%) 41.77 36.92 31.47 
Lysine (78.5%) 0.01 1.26 4.27 
Methionine (99%) 3.80 2.67 2.01 
Threonine 1.06 0.02 1.58 
Salt 10.00 10.00 10.00 
PX NCSU Br Mineral (TM90) 4.00 4.00 4.00 
Choline chloride (60) 4.00 4.00 4.00 
PX NCSU Br Vitamin (NCSU90) 1.00 1.00 1.00 
Selenium Premix NCSU (0.02%) 2.00 2.00 2.00 
Poultry fat (Miter) 10.00 10.00 10.00 
Total batch weight 2000 2000 2000 
 
3.4 White Blood Cell Differential Counts 
Blood samples were collected from one bird per replicate treatment group randomly using 
the brachial/ulna wing vena-puncture method of sampling. The blood was collected in 
heparinized micro-hematocrit tubes to avoid blood coagulation and immediately placed unto pre-
cleaned microscope slides using the two slide wedge method. All slides were marked for 
identification using an industrial permanent fade and water resistant marker. Prepared slides 
were then transported to a laboratory located on the campus of NCAT to be air dried overnight. 
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Subsequently, each slide was fixed with methanol and stained according to the HEMA 3 manual 
staining system protocol. The slides were allowed to air dry completely before examination. For 
a detailed analysis of avian WBC, all slides were examined using an oil immersion lens under 
100 x magnification by means of a compound light microscope. A total of 100 avian heterophils, 
lymphocytes, monocytes, eosinophils and basophils were identified and enumerated using 
manual counters with results expressed as percentages.  
3.5 Enzyme-Linked Immunosorbent Assay 
Whole blood samples were obtained from 3 experimentally challenged and 3 
unchallenged broilers per treatment group at the conclusion of the trial (d 49) via the jugular vein 
at the time of euthanasia. The blood was collected in tiger top collection tubes, packed on ice, 
placed into a cooler and transported to a laboratory at NCAT for processing. Serum was 
separated from whole blood using centrifugation. The sera was decanted into another set of tubes 
and stored in a minus 80°C, ultra-low temperature laboratory freezer until analyzed.  
3.5.1 Detection of chicken IgA and IgG concentrations. Chicken ELISA kits were used 
to quantify the amount of antibody levels present within the collected serum samples. Both 
standards and samples were analyzed using the Chicken (Cat. No. E33-103) kits manufactured 
by Bethyl Laboratories. All standards were ran in duplicates and all samples were ran in 
triplicates. A micropipette was used to coat a 96-well microtiter plate with the 50 ul of primary 
antigen diluted in ELISA Coating Buffer (Cat. No. E107). The microtiter plate was covered and 
incubated for 1 h at room temperature (20-25°C). The antigen was then decanted and the plate 
was washed five times with an ELISA Wash Solution buffer (Cat. No. E106) using a Nunc 
automatic plate washer. The wells where then filled with 100 ul of a blocking solution Buffer 
(Cat. No. E104) and incubated for 30 min at room temperature. The wash steps were repeated 
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before adding 50 ul of both standards and samples serially diluted in Sample/Conjugate Diluent 
10% Tween 20 (Cat. No. E108). After a 1-h incubation at room temperature, the plates were 
washed again and a second antibody conjugated with horseradish peroxidase (HRP) was added 
to the wells, followed by a 1-h incubation at room temperature. The wash steps were repeated 
followed by adding tetramethylbenzidine substrate (TMB) Enzyme Substrate, TMB (Cat. No. 
E102) to each well. The plate was then developed under low light conditions for 15 minutes. The 
reaction was stopped by adding 50 ul of stop solution ELISA Stop Solution (Cat. No. E115) to 
each occupied well. Absorbency was read at 450 nm and the total antibody titer average was 
recorded.  
3.6 Eimeria Oocyst Counts 
Pooled fecal samples were taken from broilers in each treatment group on d 49. A total of 
four birds from each group were placed into battery brooder cages where they were held 
overnight. Fresh fecal samples were collected the next day. The samples were collected in 
labeled 50 ml conical tubes, placed in a cooler with ice and transported to the Laboratory Animal 
Resource Unit at NCAT for processing. The samples were processed within 24 hours to prevent 
further oocycts development. Oocysts counts were performed using a modified version of the 
standard McMasters oocysts chamber counting technique. Two grams of fresh feces from each 
sample were weighed out using an electronic laboratory balance. Measured samples were placed 
in sterile containers and mixed thoroughly with 30 ml of sodium nitrate. The fecal suspension 
was filtered through a double layer of cheesecloth into a new container. The filtrate was mixed 
again before being transferred into both chambers of the McMaster slide. The loaded slides were 
allowed to sit for 5 minutes before analysis. Slide samples were read at a 10 x 10 magnification 
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using a compound microscope. The number of oocysts within each chamber grid were counted, 
multiplied by 50 and recorded as eggs per gram (EPG).  
3.7 Carcass and Bursa Weights  
Carcass and bursa weight percentages were determined on d 49 by selecting four birds 
per treatment group and by pooling from replicates. They were then humanly killed, de-feathered 
and eviscerated. The bursa’s were separated from the rest of the internal organs and weighed.  
3.8 Statistical Analysis 
All data except mortality percentages were analyzed using the General Linear Model 
(GLM) procedure of SAS ( SAS Institute, 2004). The Least Square Means (LSM) procedure was 
used to separate treatment means. Differences among treatment groups were determined using 
the Duncan’s multiple-range test. Mean values within the starter, grower or starter-grower-
finisher phases having the same alphabets are not significantly different at P ≤ 0.05 or P ≤ 0.1.  
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CHAPTER 4 
Results and Discussion 
4.1 Body Weights 
4.1.1 Unchallenged and challenged broiler body weight gain at 7 weeks (d 49). The 
mean body weights of unchallenged broilers on d 49 are shown in (Figure 1). Overall, there were 
no significant effects or interactions (p>0.05) on the body weights of unchallenged broilers in 
regards to dietary phase or inclusion level. In addition, there were no statistical differences found 
among the treatment levels and dietary phases of individual treatment groups. Although not 
statistically significant, there was a numerical trend improvement in the body weights of 
unchallenged broilers in treatment group 3 (1% starter-grower-finisher). 
 
Figure 1 Effects of FMG Diet on Unchallenged Broiler Body Weights d 49 
The mean body weight gains of challenged broilers are presented in (Figure 2). There 
were no statistically significant (p>0.05) effects observed among dietary phases or inclusion 
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levels on the body weight gains of challenged broilers. However, there were significant 
differences (p<0.05) observed on d 49 for broilers who were experimentally challenged with 
Eimeria. Challenged broilers belonging to treatment groups 4 (5% starter) and 7 (10% starter) 
had statistically higher (p<0.05) body weights compared to challenged broilers in treatment 
group 1 (1% starter), which had a statistically lower body weight value. While citing a numerical 
trend found among unchallenged broilers, body weight improvements were also observed for 
challenged broilers in treatment group 3 (1% starter-grower-finisher). 
 
Figure 2 Effects of FMG Diet on Challenged Broiler Body Weights d 49 
Overall, there were no statistical differences among the body weights of unchallenged 
broilers receiving FMG supplementation in the starter, grower or starter-grower-finisher phases 
at any dietary level on d 49. This may indicate that certain medicinal mushrooms fed in 
combination to chickens via FMG at different levels may offer some immune protection against 
natural Eimeria infections and may aid in growth performance. It appears that administrating 
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FMG at the 1% level to challenged broilers influenced body weights. It may be notable to 
mention the numerical improvements to body weights of both unchallenged and challenged 
broilers  in treatment group 3 (1% starter-grower-finisher).  
Natural Eimeria infections in broilers are caused by prolonged exposure to active oocyst 
found ubiquitous within their rearing environment. Shedding of oocysts by birds that are infected 
with high parasitic loads of Eimeria spp. increases the exposure and infection risks of clinically 
healthy broilers. In this study, unchallenged and experimentally challenged broilers were housed 
together within each treatment group. It was perceived that the challenged birds would serve as a 
reservoir of infection for the sentinel broilers with whom they cohabited. Reduced body weights 
in broilers are often a sign of disease. Avian coccidiosis, specifically, is a particularly detrimental 
disease of poultry and infestations can lead to intestinal hemorrhaging, impaired nutrient 
absorption and depressed growth rates (Conway & McKenzie, 2007).  
Feeding broilers a diet of 5% shiitake FMG has been shown to provide some level of 
immunity against Eimeria (Willis et al., 2011). It cannot be assumed that variations in body 
weights of unchallenged birds or challenged birds were a direct result of coccidiosis infection. 
However, a correlation between coccidiosis and induced weight depression has been documented 
in previous literature (Willis et al., 2012). Differences in body weights may also be influence by 
other factors such as the different physiochemical properties of polysaccharides and their 
biological effects on the broiler GIT (Guo, Savelkoul, Kwakkel, Williams, & Verstegen, 2003).     
4.2 Carcass Yield Percentages 
Carcass yields for unchallenged broilers on d 49 post slaughter are shown in (Figure 3). 
Dietary treatment effects and interactions on broiler carcass yields were non-significant (p>0.05). 
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In addition there were no statistical differences (p>0.05) observed in carcass yields among 
treatment groups. No carcass yields for challenged broilers were obtained from this study.  
 
Figure 3 Effects of FMG Diet on Unchallenged Broiler Carcass Yields d 49 
4.3 Mortality Percentages 
The mortality rates of broilers from placement to slaughter during a 7-week rearing 
period are represented in (Table 2). Numerically, the mortality rate percentages for broilers 
belonging to treatment groups 3 (1% starter-grower-finisher (6.6%), 4 (5% starter (10%), 5 (5% 
FMG grower (3.3%), 6 (5% starter-grower-finisher (10%), 7 (10% starter (10%), 8 (10% grower 
(6.6%) and 9 (10% starter-grower-finisher (6.6%) were relatively low. No mortalities were 
observed in treatment groups with broilers receiving 1% starter and 1% grower diets. Mortalities 
in broilers can be a result of a number of external factors. Throughout this study, signs of 
morbidity in broilers were infrequent. Mortalities observed in this study did not seem to be 
significantly influenced by treatments.  In previous investigations conducted by researchers at 
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this site, FMG supplements aided in the performance enhancement of both challenged and 
naturally infected broilers by reducing the percentage of disease related mortalities. 
Table 2 
Mortality Percentages of Broilers on d 49 
Treatment Name 
 
Group # 
 
 
 
# of Birds/Trt on d 49 
 
 
 
 
Mortality Percentage (# of Deceased Birds) 
1 % FMG-Starter 
 
1 30 0% 
1 % FMG-Grower 
 
2 30 0% 
1 % FMG- S/G/F*** 
 
3 28 6.6% (2) 
5 % FMG-Starter 
 
4 27 10% (3) 
5 % FMG-Grower 
 
5 29 3.3% (1) 
5 % FMG- S/G/F 
 
6 27 10% (3) 
10 % FMG-Starter 
 
7 27 10% (3) 
10 % FMG-Grower 
 
8 28 6.6% (2) 
10 % FMG- S/G/F 
 
9 28 6.6% (2) 
* Trt= Treatment; ** FMG = Fungus Myceliated Grain; ***S/G/F= Starter, Grower and Finisher 
4.4 Eimeria Oocyst Counts  
Eimeria oocysts counts performed on unchallenged broilers were statistically significant 
(p>0.1) between treatment groups. The oocysts counts of unchallenged broilers are shown in 
(Figure 4). However, a significant (p<0.1) effect of dietary levels on broiler fecal oocysts 
shedding was observed at the 5% level in the starter, grower and starter-grower-finisher phases. 
A numerical trend was observed for fecal oocyst elevations in the 5% inclusion levels of 
unchallenged broilers belonging to treatment groups 4 (5% starter), 5 (5% grower) and 6 (10% 
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starter-grower-finisher).  Broilers in treatment group 3 (1% starter-grower-finisher) had the 
highest overall fecal oocyst count numerically, compared to all other treatment groups.  
 
Figure 4 Effects of FMG on Eimeria oocysts Counts in Unchallenged Broilers d 49 
There were significant (p<0.05) differences in the oocysts fecal shedding of 
experimentally challenged broilers as presented in (Figure 5) on d 49. Additionally, there was a 
significant (p<0.05) interaction between dietary level and grow-out phase influenced the oocyst 
shedding in birds. Treatment group 5 (5% grower) had the highest numerical difference 
compared to that of treatment groups 2 (1% grower) and 8 (10% grower). There were no 
statistically significant (p>0.05) differences in the dietary levels in neither the starter nor the 
starter-grower-finisher phases. Eimeria oocysts counts did not appear to negatively affect the 
body weights of broiler chickens. For instance, a high oocysts count in the grower phase at the 
5% level did not cause depression in the body weights of boilers within the same treatment 
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group. In addition, the increased oocysts counts in treatment group 5 (5% grower) did not reflect 
negatively on the body weight gain of broilers within the same treatment group.  
4.5 White Blood Cell Differential Counts 
4.5.1 Heterophil counts. Heterophil values for unchallenged broilers are represented in 
(Figure 6). A significantly higher (p<0.05) heterophil differential percent value was observed in 
treatment groups 2 (1% grower) and 5 (5% grower) as compared to unchallenged broilers in 
treatment group 8 (10% starter-grower-finisher). A significantly higher (p<0.05) heterophil cell 
count was also observed in broilers belonging to treatment group number 9 (10% starter-grower-
finisher). Broilers in treatment group 6 (5% starter-grower-finisher) had a significantly lower 
heterophil value as compared to treatment group 9 (10% starter-grower-finisher). The heterophil 
values for broilers belonging to treatment group 3 (1% starter-grower-finisher) did not differ 
statistically from other treatment groups within the same experimental phase.  
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Figure 6 Effects of FMG Diet on Heterophil % of Unchallenged Broiler d 49 
A significantly higher (p<0.05) heterophil differential value was observed for challenged 
broilers in treatment group 5 (5% grower) as compared to treatment group 2 (1% grower) and 8 
(10% grower), which had significantly lower values (Figure 7). In addition, there was a 
significantly higher (p<0.05) heterophil value observed in broilers belonging to treatment group 
6 (5% starter-grower-finisher) as compared to broilers in treatment group 9 (10% starter-grower-
finisher) whose values were statistically lower. Heterophil values for broilers in treatment group 
3 (1% starter-grower-finisher) had comparable values to both treatment groups 6 (5% starter-
grower-finisher) and 9 (10% starter-grower-finisher) and therefore did not differ from them 
significantly. There were no statistical differences observed among dietary levels in the starter 
phase. Overall, heterophil values for challenged broilers in all treatment groups were slightly 
elevated. 
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Figure 7 Effects of FMG Diet on Heterophil % of Challenged Broilers d 49 
Heterophils are the second most abundant granulocyte in chickens and are proficient 
modulators of the avian immune system. Heterophils are highly phagocytic and are capable of 
generating an early primary innate response to pathogenic microbes (Harmon, 1998). The 
heterophil counts for both unchallenged and challenged chicks, in this study, fell within the 
normal avian hematological range (15-50%) (Campbell & Ellis, 2007). However, there were 
statistically significant elevations in heterophil counts among treatment groups for both 
unchallenged and challenged birds. It has been reported that heterophil numbers increase when 
birds are placed under stressful conditions (Maxwell & Robertson, 1998). Therefore, even slight 
elevations in heterophil counts may be indicative of an immunological challenge. 
4.5.2 Lymphocyte counts. Lymphocyte values for unchallenged broilers on d 49 are 
represented in (Figure 8). A statistically lower lymphocyte value was seen in broilers belonging 
to treatment group 7 (10% starter) as opposed to treatment groups 1 (1% starter) and 4 (5% 
0
5
10
15
20
25
30
35
40
45
50
Starter Grower SGF
H
e
te
ro
p
h
il 
(%
) 
Dietary Phases 
1% FMG 5% FMG 10% FMG
43 
 
starter) whose values were significantly higher (p<0.05).  The lymphocyte differential value for 
unchallenged broilers belonging to treatment group 3 (1% starter-grower-finisher) was 
significantly higher (p<0.05) than that of broilers belonging to treatment group 6 (5% starter-
grower-finisher) which was significantly lower. The lymphocyte differential values for broilers 
in treatment group 9 (10% starter-grower-finisher) did not significantly differ from treatment 
groups 3 (1% starter-grower-finisher) and 6 (5% starter-grower-finisher). Statistically, there were 
no significant differences (p>0.05) among the lymphocyte differential values of challenged 
broilers.  
 
Figure 8 Effects of FMG Diet on Lymphocyte % of Unchallenged Broilers d 49 
Lymphocytes values for challenged broilers are shown in (Figure 9). Lymphocytes cell 
values were also all within normal range according to literature (29-84%) (Campbell & Ellis, 
2007). A fluctuation in lymphocyte values may be linked to a later Eimeria challenge (d 28) than 
would normally occur naturally within a broilers environment in production. In another study, 
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broilers given a 5% FMG diet consisting of shiitake and challenged with Eimeria spp. at 28 d 
had elevated lymphocyte values when compared to other treatment groups (Willis, Isikhuemhen, 
Minor, Hurley, & Ohimain, 2010b). Generally, lymphocytes are the most numerous WBC in 
chickens and are activated upon antigenic stimulation. However, in this study, heterophil counts 
were more numerous than lymphocytes on d 49. Campbell et al., (2007) noted that 
immunologically healthy chicks should have more circulating lymphocytes than heterophils. It 
has been reported that Eimeria infections in young broilers can prompt the activation and 
proliferation of local lymphocytes (Swinkels et al., 2006). No conclusive interpretation can be 
drawn from this data. 
 
Figure 9 Effects of FMG Diet on Lymphocyte % of Challenged Broilers d 49 
4.5.3 Monocyte counts. Unchallenged boilers in treatment group 5 (5% grower) were 
significantly lower (p<0.05) than those monocyte values for broilers in treatment groups 2 (1% 
grower) and 8 (10% grower) (Figure 10). There were also statistical differences found in broilers 
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fed FMG supplementation throughout duration of the study. In treatment group 9 (10 % starter-
grower-finisher), the monocyte values for unchallenged broilers was statistically higher (p<0.05) 
than that of treatment group 3 (1% starter-grower-finisher), but did not differ statistically from 
the values of broilers in treatment group 6 (5% starter-grower-finisher).  
 
Figure 10 Effects of FMG Diet on Monocyte % of Unchallenged Broilers d 49 
The monocyte values of challenged broilers (Figure 11) were statistically higher (p<0.05) 
in treatment group 7 (10% starter) than in treatment groups 1 (1% starter) and 4 (5% starter). 
Statistical differences were not found among challenged broilers in other treatment groups. 
Monocyte cell counts had the greatest variance among hematological cells. According to 
literature, monocyte values observed within this study were not within the normal range of 0-7% 
(Campbell & Ellis, 2007). However, in a previous study involving the administration of FMG to 
broilers, monocyte values ranged from 19 and 36%  (Willis et al., 2010b). A scientific report 
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suggests that the activity of monocytes can be influenced by a variety of factors including; diet, 
environment, genetics and antigenic stimuli (Qureshi, 1998).  
 
Figure 11 Effect of FMG Diet on Monocyte % of Challenged Broilers d 49 
4.6 Chicken IgA Concentrations 
The concentrations of unchallenged broilers IgA are presented in (Figure 12). The IgA 
concentrations of unchallenged broilers in treatment group 2 (1% grower) were significantly 
higher (p<0.05) when compared to treatment group 8 (10% grower) which had a significantly 
lower concentration. Broilers in treatment group 5 had an IgA serum concentration that was 
comparable to those of both treatment groups 2 (1% grower) and 8 (10% grower). There were 
also statistically significant (p<0.05) elevations in IgA serum concentrations in broilers 
belonging to treatment group 9 (10% starter-grower-finisher). Significantly decreased (p<0.05) 
levels of chicken serum IgA concentrations were observed in treatment group 3 (1% starter-
grower-finisher). The IgA levels in broilers belonging to treatment group 6 (5% starter-grower-
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finisher) did not differ significantly from neither treatment group 3 (1% starter-grower-finisher) 
or 6 (5% starter-grower-finisher).  
 
Figure 12  Effects of FMG Diet on IgA Concentrations in Unchallenged Broilers d 49 
The IgA concentrations of challenged broilers are presented in (Figure 13). In respect to 
the IgA levels of broiler chickens experimentally challenged with common field strains of 
Eimeria, there were no statistically significant (p>0.05) differences between the dietary phase 
(p>0.05) and FMG inclusion level main effects. In addition, there were also no statistically 
significant interactions (p>0.05). However, there was a statistically significant (p<0.05) 
difference among the FMG supplemented treatment groups. Treatment groups 1 (1% starter) and 
4 (5% starter) had statistically higher IgA concentration values when compared to treatment 
group 7 (10% starter). Concentration levels of IgA were elevated in treatment group 2 (1% 
grower) which differed significantly from treatment group 8 (10% grower) but not from 
treatment group 5 (5% grower). In addition, broilers in treatment group 3 (1% starter-grower-
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finisher) had a significantly higher IgA concentration compared to broilers in treatment group 6 
(5% starter-grower-finisher).  
 
Figure 13 Effects of FMG Diet on IgA Concentrations in Challenged Broilers d 49 
Chicken IgA is the primary immunological defense against pathogens which invade the 
body of their host through mucosal surfaces, especially those lining the GIT. IgA is normally 
found in body secretions and aids in the prevention of adherence and invasion of pathogens in 
the gut (Perry, 2006). Elevations in serum IgA may be an immunological indicator of gut 
infections in chickens. In an unpublished research conducted at the at this site, it has been noted 
that elevated IgA levels in chickens were a result of feeding chicks a diet consisting of medicinal 
mushrooms which caused stimulation of the immune system.  
4.7 Chicken IgG Concentrations 
Statistically there were significant effects between the dietary phase (p<0.05) and FMG 
inclusion level main effects on the means of IgG concentrations in unchallenged broilers (Figure 
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14). There was a significant influence (p<0.05) within the dietary treatment phase on broiler IgG 
concentration levels in treatment group 4 (5% starter) which had the highest serum IgG values. 
Broilers in treatment group 1 (1% starter) had significantly lower (p<0.05) serum IgG 
concentration values.  
 
Figure 14 Effects FMG Diet on IgG Concentrations in Unchallenged Broilers d 49 
There were no statistically significant (p>0.05) dietary phase and level effects on the IgG 
concentrations of challenged broilers (Figure 15). In addition, there were no statistically 
significant observations for the IgG concentration levels among the treatment groups of 
challenged broilers. 
Avian IgG is the most abundant antibody found within the blood (Perry, 2006; Scanes et 
al., 2004). It can be found nearly anywhere in the body and is responsible for neutralizing 
antigens. IgG production is generally stimulated by infection and inflammation. The average 
concentration of IgG in the blood serum of chickens is approximately 600-1300 µg/ml (Bethyl 
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Laboratories, Inc, USA). Although serum IgG concentration values fell within normal range for 
chickens, most IgG values were elevated. 
 
Figure 15 Effects of FMG Diet on IgG Concentrations in Challenged Broilers d 49 
Elevated levels of serum IgG may serve as an indicator for chronic infections. In 
addition, as mentioned earlier, the IgG antibody in broilers is functionally similar to both 
mammalian IgG and IgA. Therefore, the elevated levels of IgG in both unchallenged and 
challenged broilers may be an indicator of a chronic parasitic infection (coccidiosis) which 
would coincide with the elevated levels of IgA which can be indicators of intestinal gut 
infections.  
4.8 Bursa Weights 
There were no statistical (p>0.05) differences found regarding the influence of dietary 
phase and level effects nor interactions on unchallenged broiler bursa weights (Figure 16). 
However, the bursa weights of broiler chicks did vary significantly (p<0.05) among treatments. 
Broilers belonging to treatment group 7 (10% starter), had significantly higher bursa weights 
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when compared to unchallenged broilers in treatment group 4 (5% starter). The bursa weights for 
broilers in treatment group 1 (1% starter) were comparable to the values observed in treatment 
groups 4 (5% starter) and 7 (10% starter) and therefore did not differ from either group 
statistically. Unchallenged broilers in treatment group 9 (10% starter-grower-finisher) had the 
highest overall bursa weight values for broilers being fed a supplemental diet of FMG in all 
dietary phases. Broilers in treatment group 3 (1 % starter-grower-finisher) had significantly 
lower (p<0.05) bursa weight values when compared to treatment group 9 (10% starter-grower-
finisher). Overall, broilers supplemented with dietary FMG in the grower phase had numerically 
lower bursa values as compared to broilers receiving FMG in the starter and starter-grower-
finisher phases. 
The Bursa of Fabricius is an essential lymphoid organ in chickens that plays an important 
role in adaptive immunity. Bursa size can reflect the immunological health status of birds (Glick, 
1979). Healthy broilers produce larger bursas than broilers whose immune systems have been 
compromised (Glick, Chang, & Jaap, 1956). Glick et al., (1956), also reported that the Bursa of 
Fabricius plays an important role in antibody production. Therefore, it may be perceived that 
unchallenged broilers in treatment groups with higher bursa have superior immune systems 
compared to broilers whose bursa weights were smaller. Although, there is no apparent evidence 
that bursa size had any significant influence on the lymphocyte values or antibody titers of 
unchallenged broilers in this study, there has been a noticeable immunological response to 
Eimeria infections in both challenged and unchallenged broilers. In addition, there have been 
reports that have indicated positive effects on the integrity of the immune system of chickens 
given medicinal mushrooms in their diets (Guo et al., 2004a; Willis et al., 2012; Willis et al., 
2013). Therefore, it may be suggested that broiler diets supplemented with certain mushrooms 
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can exert positive health attributes via bursa performance. There are no data from challenged 
broiler bursa weights presented for comparison. 
 
Figure 16 Effects of FMG Diet on Unchallenged Broiler Bursa Weights d 49 
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CHAPTER 5  
Summary and Conclusion 
The present study was designed to evaluate the effects of dietary FMG supplements 
administered to broiler chicks at different dietary phases and at different stages of development 
on broiler performance and health. A positive impact from the medicinal mushrooms utilized in 
this study was observed in the performance enhancement protection of broilers having been 
exposed to Eimeria spp. The final body weights of both experimentally challenged and naturally 
exposed broilers were primarily uniform and did not reflect the loss in weight normally 
associated with chickens clinically infected with coccidiosis. Chickens that were directly 
challenged with Eimeria spp. and administered a diet supplemented with FMG at the 1% 
inclusion level within the starter phase showed a significant depression in body weight compared 
to all other treatment groups. Although depressed body weights can be a result of many different 
factors, it is quite possible that supplying chicks with a relatively low inclusion of FMG at a 
young age does not provide enough protection against avian coccidiosis. On the contrary, based 
on numerical trends, broilers in both the unchallenged and challenged treatment groups had 
better growth performance when supplemented with a 1% inclusion of FMG in the grower and 
starter-grower-finisher phases.  
At the end of the trial, chickens who were directly challenged with Eimeria spp., that had 
been given diets supplemented with FMG at all inclusion levels and in all grow-out phases had 
relatively low fecal oocyst counts with the exception of broilers who received a 5% FMG 
inclusion within the grower phase. In general, the parasitic load of both unchallenged and 
challenged broilers did not negatively impact their final body weights. Relatively low mortality 
rates support the positive effect that FMG supplementation had on broilers’ performance within 
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all treatment groups. Therefore, it cannot be concluded as to whether or not it may be reasonable 
to avoid administering a combination of medicinal mushrooms to broilers at the 5% inclusion 
level in the grower phase based upon observations in oocyst output and shedding. However, a 
relatively low amount of fecal oocysts shedding in the starter and grower phases of unchallenged 
broilers, and in the starter and starter-grower-finisher phases of challenged broilers can be linked 
to improved performance via FMG supplementation at the 1%, 5% and 10% inclusion levels. 
Fluctuations in avian hematological values have been reported as being a normal 
occurrence. Percent values for heterophils and lymphocytes in both challenged and unchallenged 
broilers were within the normal hematological range for chickens. Monocyte values, however, 
where notably elevated and could be indicative of infection. Although, based on the observations 
of relatively low oocysts counts in both unchallenged and challenged broilers, it cannot be 
proposed that the increase in monocyte values were in direct relation to Eimeria spp. infection. 
Observed elevations in the IgA and IgG concentration levels of both unchallenged and 
challenged broilers did not conclusively indicate whether or not FMG supplementation had any 
influence on the immunological response of broilers. However, it appears that higher levels of 
IgA at the 1% inclusion level in the grower phase of both unchallenged and challenged broilers 
were superior to that of any other treatment group and may be indicative of nutrition based 
immune enhancement.  
From the data obtained from this study, it can be concluded that that use of FMG in the 
diets of chickens exposed to Eimeria has an effect on performance and health. However, due to 
the variability in the results found between each measured parameter, it is difficult to interpret 
the exact influence that FMG had on the performance and health of broilers in one particular 
diet.  
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5.1 Recommendations 
Future research is required to determine which level of dietary FMG and at which stage 
of growth is optimal for broiler performance and health. Broilers in this study were challenged 
with Eimeria spp. later than what is normally observed with natural infections; therefore the 
potential impact of parasitic burden may not have been reflected in broiler performance and 
health parameters. Future investigations should be conducted in which all broilers are challenged 
with Eimeria spp. within a period of time that natural Eimeria infections would normally occur. 
Further studies should compare the performance and health parameters of broilers that are 
experimentally challenged with Eimeria separately from birds with natural infections. A trial set 
up in this way may generate more conclusive observations on performance and health 
parameters. A larger sample size of broilers may result in improved data analysis and reduce 
variability in parameter measurements.  
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